Stock Screener App

Gratuito -

Installare

41.57

0.38% -0.1338

Enliven Therapeutics Inc (ELVN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Enliven Therapeutics Inc Azioni (ELVN) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	36.62% 34.28	25.10	-	31.69	26.90
Operating Income/Loss	36.62% -34.28	-25.10	-	-31.69	-26.90
Nonoperating Income/Loss	6.67% 4.618	4.948	-	3.149	3.716
Income/Loss From Continuing Operations Before Tax	47.25% -29.67	-20.15	-25.34	-28.54	-23.18
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	47.25% -29.67	-20.15	-25.34	-28.54	-23.18
Net Income/Loss	47.25% -29.67	-20.15	-25.34	-28.54	-23.18
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	96.99% 1.8701	62.09	-	50.05	0.9354
Diluted Average Shares	96.99% 1.8701	62.09	-	50.05	0.9354
Basic Earnings Per Share	50.00% -0.48	-0.32	-	-0.57	-0.46
Diluted Earnings Per Share	50.00% -0.48	-0.32	-	-0.57	-0.46
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ROIV

$28.12

1.17%

RPRX

$50.01

1.05%

BNTX

$99.53

2.04%

RVMD

$139.48

3.22%

INSM

$140.13

5.16%

ONC

$296.73

1.00%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters